Seres Therapeutics, Inc.
MCRBFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Seres Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 19, 2026. The latest institutional report shown is dated Jun 30, 2025; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| OSAIC HOLDINGS, INC. | 2025-06-30 | 160 | Not shown | SEC filing |
| Kestra Advisory Services, LLC | 2025-03-31 | 38,471 | Not shown | SEC filing |
| Janney Montgomery Scott LLC | 2025-03-31 | 20,000 | Not shown | SEC filing |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 2025-03-31 | 250,000 | Not shown | SEC filing |
| Sandy Spring Bank | 2025-03-31 | 345 | Not shown | SEC filing |
| GOLDMAN SACHS GROUP INC | 2025-03-31 | 74,629 | Not shown | SEC filing |
| Invesco Ltd. | 2025-03-31 | 136,572 | Not shown | SEC filing |
| MORGAN STANLEY | 2025-03-31 | 149,604 | Not shown | SEC filing |
| WELLS FARGO & COMPANY/MN | 2025-03-31 | 7,800 | Not shown | SEC filing |
| ROYAL BANK OF CANADA | 2025-03-31 | 4,444 | Not shown | SEC filing |
| Schonfeld Strategic Advisors LLC | 2025-03-31 | 51,300 | Not shown | SEC filing |
| NORTHERN TRUST CORP | 2025-03-31 | 301,564 | Not shown | SEC filing |
| GEODE CAPITAL MANAGEMENT, LLC | 2025-03-31 | 1,618,772 | Not shown | SEC filing |
| CITIGROUP INC | 2025-03-31 | 215 | Not shown | SEC filing |
| PEAPACK GLADSTONE FINANCIAL CORP | 2025-03-31 | 13,000 | Not shown | SEC filing |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 2025-03-31 | 0 | $0 | SEC filing |
| Vanguard Personalized Indexing Management, LLC | 2025-03-31 | 50,720 | Not shown | SEC filing |
| BARCLAYS PLC | 2025-03-31 | 1,593 | Not shown | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2025-03-31 | 6,137 | Not shown | SEC filing |
| AVANTAX ADVISORY SERVICES, INC. | 2025-03-31 | 45,179 | Not shown | SEC filing |
- Each value is checked against Seres Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 19 rows: no share price from within three months of their report dates is on file, so they could not be checked.
Filer report history
Two reports per filer, as filed. No change is calculated, because the data on file cannot confirm that both reports describe the same security.
- OSAIC HOLDINGS, INC.: 160 shares reported 2025-03-31; 160 shares reported 2025-06-30.
- VICTORY CAPITAL MANAGEMENT INC: 15,439 shares reported 2024-12-31; 15,342 shares reported 2025-03-31.
- Integrated Wealth Concepts LLC: 10,000 shares reported 2024-12-31; 10,000 shares reported 2025-03-31.
- STIFEL FINANCIAL CORP: 20,000 shares reported 2024-12-31; 20,000 shares reported 2025-03-31.
- Sound Income Strategies, LLC: 175 shares reported 2024-12-31; 175 shares reported 2025-03-31.
- MML INVESTORS SERVICES, LLC: 15,864 shares reported 2024-12-31; 15,864 shares reported 2025-03-31.
- LPL Financial LLC: 94,787 shares reported 2024-12-31; 95,137 shares reported 2025-03-31.
- COMMONWEALTH EQUITY SERVICES, LLC: 11,598 shares reported 2024-12-31; 11,598 shares reported 2025-03-31.
- UBS Group AG: 342,317 shares reported 2024-12-31; 1,456,161 shares reported 2025-03-31.
- Vontobel Holding Ltd.: 938,295 shares reported 2024-12-31; 1,085,966 shares reported 2025-03-31.
- CANTOR FITZGERALD, L. P.: 95,740 shares reported 2024-12-31; 37,475 shares reported 2025-03-31.
- Aries Wealth Management: 15,000 shares reported 2024-12-31; 15,000 shares reported 2025-03-31.
Showing the 12 most recent filer reports.
32 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Seres Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-02-18 · Shaff Eric D.: Larger than 49 of the 50 other insider sales of Common Stock on file. SEC filing
- 2025-02-18 · von Moltke Lisa: Larger than 46 of the 50 other insider sales of Common Stock on file. SEC filing
- 2024-10-28 · von Moltke Lisa: Larger than 45 of the 50 other insider sales of Common Stock on file. SEC filing
- 2024-10-28 · Shaff Eric D.: Larger than 47 of the 50 other insider sales of Common Stock on file. SEC filing
- 2024-08-05 · Young Teresa L.: Larger than all 50 other insider sales of Common Stock on file. SEC filing
- 2024-02-16 · Shaff Eric D.: Larger than 48 of the 50 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-18 | Shaff Eric D. · Director | Common Stock | S — Open market or private sale | −259 | 7.53 | SEC filing |
| 2026-05-18 | Henn Matthew R · See Remarks | Common Stock | S — Open market or private sale | −77 | 7.53 | SEC filing |
| 2026-05-18 | DesRosier Thomas · See Remarks | Common Stock | S — Open market or private sale | −79 | 7.53 | SEC filing |
| 2026-05-18 | Brady Kelly · See Remarks | Common Stock | S — Open market or private sale | −59 | 7.53 | SEC filing |
| 2026-02-15 | DesRosier Thomas · See Remarks | Common Stock | S — Open market or private sale | −78 | 8.47 | SEC filing |
| 2026-02-15 | Shaff Eric D. · Director | Common Stock | S — Open market or private sale | −259 | 8.47 | SEC filing |
| 2026-02-15 | Young Teresa L. · See Remarks | Common Stock | S — Open market or private sale | −75 | 8.47 | SEC filing |
| 2026-02-15 | Henn Matthew R · See Remarks | Common Stock | S — Open market or private sale | −89 | 8.47 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-05-15 | Brady Kelly · See Remarks | Restricted Stock Units | M — Exercise or conversion of derivative security | −91 | SEC filing |
| 2026-05-15 | Shaff Eric D. · Director | Restricted Stock Units | M — Exercise or conversion of derivative security | −391 | SEC filing |
| 2026-05-15 | Henn Matthew R · See Remarks | Restricted Stock Units | M — Exercise or conversion of derivative security | −141 | SEC filing |
| 2026-05-15 | DesRosier Thomas · See Remarks | Restricted Stock Units | M — Exercise or conversion of derivative security | −111 | SEC filing |
| 2026-05-15 | DesRosier Thomas · See Remarks | Common Stock | M — Exercise or conversion of derivative security | +244 | SEC filing |
| 2026-05-15 | Henn Matthew R · See Remarks | Restricted Stock Units | M — Exercise or conversion of derivative security | −97 | SEC filing |
| 2026-05-15 | Shaff Eric D. · Director | Common Stock | M — Exercise or conversion of derivative security | +722 | SEC filing |
| 2026-05-15 | Brady Kelly · See Remarks | Common Stock | M — Exercise or conversion of derivative security | +180 | SEC filing |
Showing 8 of 20 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.